House Bill 1123
2023-2024 Regular Session
An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.
Co-Sponsorship Memo
Prime Sponsor
Representative Dawn Keefer
R House District 92
Co-Sponsors
Rep. Joe Hamm
R House District 84
Rep. Rob Kauffman
R House District 89
Rep. Joseph D'Orsie
R House District 47
Rep. David Rowe
R House District 85
Rep. David Zimmerman
R House District 99
Rep. Barbara Gleim
R House District 199
Rep. Robert Leadbeter
R House District 109
Bill Status & History
Last Action: Referred to Health, May 5, 2023
House
H
S
Printers Numbers
Votes
There are no votes available.
Committee Meetings
There are no committee meetings available.
Statute References
There are no statute references for this bill.
House Bill 1123
2023-2024 Regular Session
Sponsors
KEEFER, HAMM, KAUFFMAN, D'ORSIE, ROWE, ZIMMERMAN, GLEIM, LEADBETER
Short Title
An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.
Memo Subject
Off-Label Prescribing for Respiratory Syndrome Related Illnesses
Actions
| 1178 | Referred to HEALTH, May 5, 2023 |
Generated 09/16/2024 04:13 PM